NanoBiT- and NanoBiT/BRET-based assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model.


Journal article


Lukas Grätz, J. J. Sajkowska-Kozielewicz, Janine Wesslowski, Julia Kinsolving, L. Bridge, Katja Petzold, G. Davidson, G. Schulte, P. Kozielewicz
British Journal of Pharmacology, 2023

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Grätz, L., Sajkowska-Kozielewicz, J. J., Wesslowski, J., Kinsolving, J., Bridge, L., Petzold, K., … Kozielewicz, P. (2023). NanoBiT- and NanoBiT/BRET-based assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model. British Journal of Pharmacology.


Chicago/Turabian   Click to copy
Grätz, Lukas, J. J. Sajkowska-Kozielewicz, Janine Wesslowski, Julia Kinsolving, L. Bridge, Katja Petzold, G. Davidson, G. Schulte, and P. Kozielewicz. “NanoBiT- and NanoBiT/BRET-Based Assays Allow the Analysis of Binding Kinetics of WNT-3A to Endogenous Frizzled 7 in a Colorectal Cancer Model.” British Journal of Pharmacology (2023).


MLA   Click to copy
Grätz, Lukas, et al. “NanoBiT- and NanoBiT/BRET-Based Assays Allow the Analysis of Binding Kinetics of WNT-3A to Endogenous Frizzled 7 in a Colorectal Cancer Model.” British Journal of Pharmacology, 2023.


BibTeX   Click to copy

@article{lukas2023a,
  title = {NanoBiT- and NanoBiT/BRET-based assays allow the analysis of binding kinetics of WNT-3A to endogenous Frizzled 7 in a colorectal cancer model.},
  year = {2023},
  journal = {British Journal of Pharmacology},
  author = {Grätz, Lukas and Sajkowska-Kozielewicz, J. J. and Wesslowski, Janine and Kinsolving, Julia and Bridge, L. and Petzold, Katja and Davidson, G. and Schulte, G. and Kozielewicz, P.}
}

Abstract

BACKGROUND AND PURPOSE WNT binding to Frizzleds (FZD) is a crucial step that leads to the initiation of signalling cascades governing multiple processes during embryonic development, stem cell regulation, and adult tissue homeostasis. Recent efforts have enabled us to shed light on WNT-FZD pharmacology in overexpressed HEK293 cells. However, assessing ligand binding at endogenous receptor expression levels is important as there might be differential binding behaviour in a native environment. Here, we study one FZD paralogue: FZD7 , and analyze its interactions with WNT-3A in live CRISPR-Cas9-edited SW480 cells typifying colorectal cancer.

EXPERIMENTAL APPROACH SW480 cells were CRISPR-Cas9-edited to insert a HiBiT-tag on the N-terminus of FZD7 , preserving the native signal peptide. Subsequently, these cells were used to study eGFP-WNT-3A association with endogenous and overexpressed HiBiT-FZD7 using NanoBiT/BRET and NanoBiT to measure ligand binding and receptor internalization.

KEY RESULTS Using the newly developed assay, we detect the binding of eGFP-WNT-3A to endogenous HiBiT-FZD7 and compare it with overexpressed receptors. We show that receptor overexpression results in increased membrane dynamics, leading to an apparent decrease in binding on-rate and consequently in higher, up to 10 times, calculated Kd . Thus, measurements of binding affinities of WNT-3A to FZD7 obtained in overexpressed cells are suboptimal compared to the measurements from endogenously-expressing cells.

CONCLUSIONS AND IMPLICATIONS Binding affinity measurements in the overexpressing cells fail to recapitulate ligand binding affinities assessed in a (patho-)physiologically relevant context where receptor expression is lower. Therefore, future studies on WNT-FZD7 binding should be performed using receptors expressed under endogenous promotion.


Share




Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in